More than memory impairment in voltage-gated potassium channel complex encephalopathy
- PMID: 24981998
- PMCID: PMC4162838
- DOI: 10.1111/ene.12482
More than memory impairment in voltage-gated potassium channel complex encephalopathy
Abstract
Background and purpose: Autoimmune encephalopathies (AEs) are a heterogeneous group of neurological disorders that affect cognition. Although memory difficulties are commonly endorsed, few reports of AEs inclusively assess all cognitive domains in detail. Our aim was to perform an unbiased cognitive evaluation of AE patients with voltage-gated potassium channel complex antibodies (VGKCC -Abs) in order to delineate cognitive strengths and weaknesses.
Methods: Serial VGKCC -Ab AE subjects (n = 12) were assessed with a comprehensive evaluation of memory, executive functions, visuospatial skills and language. Clinical magnetic resonance imaging (MRI) (n = 10/12) was evaluated. Five subjects had serial cognitive testing available, permitting descriptive analysis of change.
Results: Subjects demonstrated mild to moderate impairment in memory (mean Z = -1.9) and executive functions (mean Z = -1.5), with variable impairments in language and sparing of visuospatial skills. MRI findings showed T2 hyperintensities in medial temporal lobe (10/10) and basal ganglia (2/10). Serial cognitive examination revealed heterogeneity in cognitive function; whereas most patients improved in one or more domains, residual impairments were observed in some patients.
Conclusions: This study augments previous neuropsychological analyses in VGKCC -Ab AE by identifying not only memory and executive function deficits but also language impairments, with preservation of visuospatial functioning. The study further highlights the importance of domain-specific testing to parse out the complex cognitive phenotypes of VGKCC -Ab AE.
Keywords: LGI1; autoimmune; cognitive.
© 2014 The Author(s) European Journal of Neurology © 2014 EAN.
Conflict of interest statement
Dr. Gelfand has provided expert witness medical-legal consultation related to CNS inflammatory-demyelinating diseases. Dr. Irani is a coapplicant on a patent for LGI1 and CASPR2 antibody discovery and receives related royalties. Dr. Hess receives research support from General Electric. Dr. Geschwind served as a consultant for MedaCorp, The Council of Advisors, Guidepoint Global, and Neurophage.
Figures

References
-
- Irani SR, Vincent A. Autoimmune encephalitis -- new awareness, challenging questions. Discov. Med. 2011 May;11(60):449–458. - PubMed
-
- Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004 Mar;127(Pt 3):701–712. - PubMed
-
- Kartsounis LD, de Silva R. Unusual amnesia in a patient with VGKC-Ab limbic encephalitis: a case study. Cortex. 2011 Apr;47(4):451–459. - PubMed
-
- Chan D, Henley SM, Rossor MN, Warrington EK. Extensive and temporally ungraded retrograde amnesia in encephalitis associated with antibodies to voltage-gated potassium channels. Arch. Neurol. 2007 Mar;64(3):404–410. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P50 AG023501/AG/NIA NIH HHS/United States
- K23AG042492/AG/NIA NIH HHS/United States
- KL2 TR000143/TR/NCATS NIH HHS/United States
- P50AG023501/AG/NIA NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- P01 AG021601/AG/NIA NIH HHS/United States
- R01AG031189/AG/NIA NIH HHS/United States
- K23AG021989/AG/NIA NIH HHS/United States
- P01AG021601/AG/NIA NIH HHS/United States
- R01 AG031189/AG/NIA NIH HHS/United States
- K23 AG021989/AG/NIA NIH HHS/United States
- N01-NS-0-2328/NS/NINDS NIH HHS/United States
- K23 AG042492/AG/NIA NIH HHS/United States
- KL2TR000143/TR/NCATS NIH HHS/United States
- UL1RR024131/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical